Hbk Sorce Advisory LLC Vaxart, Inc. Transaction History
Hbk Sorce Advisory LLC
- $3.02 Billion
- Q3 2025
A detailed history of Hbk Sorce Advisory LLC transactions in Vaxart, Inc. stock. As of the latest transaction made, Hbk Sorce Advisory LLC holds 75,118 shares of VXRT stock, worth $30,798. This represents 0.0% of its overall portfolio holdings.
Number of Shares
75,118
Previous 75,118
-0.0%
Holding current value
$30,798
Previous $27,000
-0.0%
% of portfolio
0.0%
Previous 0.0%
Shares
3 transactions
Others Institutions Holding VXRT
# of Institutions
44Shares Held
6.06MCall Options Held
50.3KPut Options Held
0-
Marshall Wace, LLP London, X01.95MShares$800,7450.0% of portfolio
-
Black Rock Inc. New York, NY1.77MShares$727,4810.0% of portfolio
-
Raymond James Financial Services Advisors, Inc. St. Petersburg, FL188KShares$77,2370.0% of portfolio
-
Xtx Topco LTD London, X094.3KShares$38,6450.0% of portfolio
-
Beacon Capital Management, LLC60.3KShares$24,7280.0% of portfolio
About Vaxart, Inc.
- Ticker VXRT
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 126,506,000
- Market Cap $51.9M
- Description
- Vaxart, Inc., a clinical-stage biotechnology company, engages in the discovery and development of oral recombinant protein vaccines based on its proprietary oral vaccine platform. The company's product pipeline includes norovirus vaccine, an oral tablet vaccine, which is in a Phase Ib clinical trial with bivalent oral tablet vaccine for the GI.1...